Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus

Fig 6

Mean profiles of AT-511 and its metabolites in rat plasma over 24 h.

Sprague-Dawley rats (3 male and 3 female) were administered a 300 mg/kg single oral dose of AT-527 and plasma concentrations of AT-511, AT-273, M1 and M4 were measured by LC-MS/MS. Data are mean ± SD of all 6 animals.

Fig 6